Literature DB >> 17203357

Malignant non-functional paraganglioma of the bladder presenting with azotemia.

Rajiv Yadav1, Anup Kumar Das, Rajeev Kumar.   

Abstract

Paragangliomas of the urinary bladder are rare tumors representing less than 1% of bladder tumors and are usually benign. Malignant paragangliomas are uncommon and are defined by their clinical behavior rather than the histologic features. We describe a patient with recurrent nonfunctioning paraganglioma of bladder presenting with hematuria and obstructive uropathy due to involvement of ureteroileal anastomoses. Treatment consisted of excision of recurrent lesion involving both lower ureters with the revision of ureteroileal anastomoses. Histology confirmed the presence of nests of tumor cells with abundant eosinophilic cytoplasm. Immunohistochemically the tumor cells were strongly positive for chromogranin A.

Entities:  

Mesh:

Year:  2007        PMID: 17203357     DOI: 10.1007/s11255-006-9017-5

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Malignant phaeochromocytoma with functioning metastases.

Authors:  P DAVIS; W S PEART; W VAN'T HOFF
Journal:  Lancet       Date:  1955-08-06       Impact factor: 79.321

2.  One hundred cases of pheochromocytoma (107 tumors) at the Columbia-Presbyterian Medical Center, 1926-1976: a clinicopathological analysis.

Authors:  M M Melicow
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

Review 3.  Pathology of the adrenal gland.

Authors:  W E Grizzle
Journal:  Semin Roentgenol       Date:  1988-10       Impact factor: 0.800

Review 4.  Pheochromocytoma: a clinical and experimental overview.

Authors:  W M Manger; R W Gifford; B B Hoffman
Journal:  Curr Probl Cancer       Date:  1985-05       Impact factor: 3.187

Review 5.  Pheochromocytoma of the bladder: case report and summary of literature.

Authors:  R B Bourne; E Beltaos
Journal:  J Urol       Date:  1967-09       Impact factor: 7.450

6.  Phaeochromocytoma of the urinary bladder.

Authors:  P M Higgins; G C Tresidder
Journal:  Br Med J       Date:  1966-07-30

Review 7.  Pheochromocytoma of the urinary bladder.

Authors:  P M Sweetser; D A Ohl; N W Thompson
Journal:  Surgery       Date:  1991-05       Impact factor: 3.982

8.  The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.

Authors:  L Troncone; V Rufini; P Montemaggi; F M Danza; A Lasorella; R Mastrangelo
Journal:  Eur J Nucl Med       Date:  1990

9.  Pheochromocytoma of the urinary bladder. Report of 2 cases with ultrastructural and immunohistochemical analyses.

Authors:  J O Salo; M Miettinen; J Mäkinen; T Lehtonen
Journal:  Eur Urol       Date:  1989       Impact factor: 20.096

10.  Malignant paraganglioma of the urinary bladder. A case report.

Authors:  M S Ansari; A Goel; S Goel; L N Durairajan; A Seth
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

  10 in total
  4 in total

Review 1.  Neuroendocrine Neoplasms of the Female Genitourinary Tract: A Comprehensive Overview.

Authors:  Mayur Virarkar; Sai Swarupa Vulasala; Dheeraj Gopireddy; Ajaykumar C Morani; Taher Daoud; Rebecca Waters; Priya Bhosale
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 2.  Neuroendocrine Tumors of the Urinary Bladder According to the 2016 World Health Organization Classification: Molecular and Clinical Characteristics.

Authors:  Erik Kouba; Liang Cheng
Journal:  Endocr Pathol       Date:  2016-09       Impact factor: 3.943

3.  Urinary bladder paraganglioma presenting as micturition-induced palpitations, dyspnea, and angina.

Authors:  Arindam Bagchi; Kola Dushaj; Anup Shrestha; Anatoly L Leytin; Shamsul A Bhuiyan; Farshid Radparvar; Shlomo Topchik; Sandeep Singh Tuli; Paul Kim; Sanjiv Bakshi
Journal:  Am J Case Rep       Date:  2015-05-12

4.  Non-functioning paraganglioma of the urinary bladder: A case report and review of the literature.

Authors:  Yongqing Lai; Duqun Chen; Zuhu Yu; Liangchao Ni; Shangqi Yang
Journal:  Oncol Lett       Date:  2014-01-10       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.